Low PET uptake may mask aortic sarcoma

• by Andrea Surnit

• November 4, 2026

The AI-POCUS Revolution is Here—Are Family Physicians and Our Health Systems Ready?

• by Daria Szkwarko, Hussein Elias, Mena Ramos, Kevin Bergman

• September 1, 2026

FDA Approves New Iohexol Vials

The approval includes additional 300 mg iodine/mL and 350 mg iodine/mL vial presentations.

• by Kathryn Wighton

• July 17, 2026

• 2 min

A multicenter randomized, double-blinded placebo-controlled phase 2 trial to evaluate safety and efficacy of ilofotase alfa in patients at risk for kidney injury following open heart surgery

• by Louis Mourisse, Marlies Ostermann, Steven Thiessen, Alexander Dumoulin, Alexander P. J. Vlaar, Eric Hoste, Selim Mosbahi, Antoine Schneider, Alexander Zarbock, Johannes Boehm, Peter Rosenberger, Matthias Thielmann, Eric Dubois, Jonah Powell-Tuck, Kamran Baig, Wencke Renette, Ingrid Meex, Margreet Klop-Rhiel, Krijna Opschoor, Wim Vandenberghe, Matthias Siepe, Christian Strauss, Felix Wirth, Matthias Winkel, Liesbeth Hof, Maarten Kraan, Juliane Bernholz, Peter Pickkers

• September 21, 2026